The Middle East & Africa opioids market was valued at US$ 249.22 million in 2022 and is expected to reach US$ 299.79 million by 2030; it is estimated to register a CAGR of 2.3% from 2022 to 2030.
Surging Chronic Pain Incidence Bolster Middle East & Africa Opioids Market
Chronic diseases such as cardiovascular disease, cancer, musculoskeletal diseases, and neurovascular diseases critically affect a person's health by lowering immunity. Moreover, many patients suffering from these conditions experiences chronic pain. The diseases mentioned above are most common in adults and the geriatric population. Nevertheless, cases of these diseases are noticeably growing among children as well. Chronic pain is also common among sportspersons, athletes, and individuals living with past injuries. According to a study published in the NCBI (i.e., National Center for Biotechnology Information), 20% of adults suffer from pain worldwide, and 10% are newly diagnosed with chronic pain per year. While pain affects all populations, regardless of sex, race/ethnicity, income, age, or geography, it is not distributed equally across the world. Prescription opioids, including hydrocodone, oxycodone, and morphine, are potent pain-reducing medications that are used to treat pain caused by injuries, surgeries, and health conditions such as cancer and arthritis.
According to the Congressional Research Service, Americans may get more opioids at the expense of more comprehensive pain therapies. Increased opioid prescribing practices can be attributed to the insurance reimbursement programs that incentivize opioids over alternative pain treatments, cost structures that encourage more efficient care, and evaluations that combine patient satisfaction with effective pain management. Therefore, owing to the advantage of opioids in pain management, the demand is rising among patients with chronic diseases.
Middle East & Africa Opioids Market Overview
The opioids market in the Middle East & Africa is segmented into South Africa, the UAE, Saudi Arabia, and the Rest of Middle East & Africa. In the Middle East & Africa, opioids are used for pain relief, palliative care, and de-addiction of opioids. The standard of care for opioid use disorder involves treatment using medications such as methadone, buprenorphine, or naltrexone; these medications for opioid use disorder (MOUD) reduce opioid overdose deaths. In 2020, MOUD was only available as a treatment modality for opioid use disorder in Lebanon, Morocco, Iran, and the Palestinian Territories. Despite increasing economic and healthcare development in a few countries of the region, there has been a limited increase in opioid consumption in the Middle East & Africa.
Middle East & Africa Opioids Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Opioids Market Segmentation
The Middle East & Africa opioids market is categorized into product, application, route of administration, distribution channel, and country.
Based on product, the Middle East & Africa opioids market is segmented immediate release short acting opioid and extended release long acting opioid. The immediate release short acting opioid segment held a larger market share in 2022. The immediate release short acting opioid is further sub segmented into oxycodone, hydrocodone, tramadol, codeine, propoxyphene, and others. The extended release long acting opioid is further sub segmented into oxycodone, fentanyl, morphine, methadone, and others.
In terms of application, the Middle East & Africa opioids market is categorized into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management segment held the largest market share in 2022.
By route of administration, the Middle East & Africa opioids market is segmented into oral, injectable, and transdermal patch. The oral segment held the largest market share in 2022.
By distribution channel, the Middle East & Africa opioids market is bifurcated into hospital pharmacies and retail pharmacies. The hospital pharmacies segment held a larger market share in 2022.
By country, the Middle East & Africa opioids market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa opioids market share in 2022.
Neuraxpharm Pharmaceuticals SL, Endo International plc, Hikma Pharmaceuticals Plc, Mallinckrodt Plc, Rusan Pharma Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the Middle East & Africa opioids market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 249.22 Million |
| Market Size by 2030 | US$ 299.79 Million |
| CAGR (2022 - 2030) | 2.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East & Africa Opioids Market is valued at US$ 249.22 Million in 2022, it is projected to reach US$ 299.79 Million by 2030.
As per our report Middle East & Africa Opioids Market, the market size is valued at US$ 249.22 Million in 2022, projecting it to reach US$ 299.79 Million by 2030. This translates to a CAGR of approximately 2.3% during the forecast period.
The Middle East & Africa Opioids Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Opioids Market report:
The Middle East & Africa Opioids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Opioids Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Opioids Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Opioids Market
